Showing results (321-330 of 354) with videos related to
Sort By:
Pageof 36
Head & Neck|June 8, 2021
Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomasHarman S Parhar, Gregory S Weinstein, Bert W O'Malley, et al.Brain Imaging and Behavior|March 9, 2019
A magnetic resonance spectroscopy investigation in symptomatic former NFL playersMichael L Alosco, Yorghos Tripodis, Benjamin Rowland, et al.JAMA Otolaryngology-- Head & Neck Surgery|December 9, 2016
Transoral Robotic Surgery-Assisted Endoscopy With Primary Site Detection and Treatment in Occult Mucosal PrimariesKyle M Hatten, Bert W O'Malley, Andres M Bur, et al.The Laryngoscope|August 13, 2025
Outcomes of HPV+ Oropharyngeal Carcinoma of Unknown Primary Following Transoral Robotic SurgeryTheodore A Gobillot, Gregory Weinstein, Austin Cao, et al.NMR in Biomedicine|February 9, 2021
Minimum Reporting Standards for in vivo Magnetic Resonance Spectroscopy (MRSinMRS): Experts' consensus recommendationsAlexander Lin, Ovidiu Andronesi, Wolfgang Bogner, et al.Journal of the National Cancer Institute|April 16, 2020
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving ImmunotherapyJahan J Mohiuddin, Brian Chu, Andrea Facciabene, et al.Advances in Radiation Oncology|March 18, 2021
The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance DenialMike Hernandez, J Jack Lee, Beow Y Yeap, et al.Oral Oncology|September 2, 2021
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgeryChristopher M Wright, Daniel Y Lee, David Shimunov, et al.Oral Oncology|May 1, 2021
Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgeryChristina M Yver, David Shimunov, Gregory S Weinstein, et al.International Journal of Radiation Oncology, Biology, Physics|December 1, 2019
A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the OropharynxSamuel Swisher-McClure, John N Lukens, Charu Aggarwal, et al.Pageof 36